730 related articles for article (PubMed ID: 17991305)
1. Evaluation of immune responses raised against Tc13 antigens of Trypanosoma cruzi in the outcome of murine experimental infection.
García GA; Arnaiz MR; Esteva MI; Laucella SA; Garavaglia PA; Ibarra SE; Ruiz AM
Parasitology; 2008 Mar; 135(3):347-57. PubMed ID: 17991305
[TBL] [Abstract][Full Text] [Related]
2. Immunological and pathological responses in BALB/c mice induced by genetic administration of Tc 13 Tul antigen of Trypanosoma cruzi.
García GA; Arnaiz MR; Laucella SA; Esteva MI; Ainciart N; Riarte A; Garavaglia PA; Fichera LE; Ruiz AM
Parasitology; 2006 Jun; 132(Pt 6):855-66. PubMed ID: 16478565
[TBL] [Abstract][Full Text] [Related]
3. [Immune response to Trypanosoma cruzi. An approach to the pathogenesis of Chagas' disease].
Braun M; de Titto E
Acta Physiol Pharmacol Latinoam; 1985; 35(1):1-47. PubMed ID: 2932884
[TBL] [Abstract][Full Text] [Related]
4. Kinetic analysis of antigen-specific immune responses in resistant and susceptible mice during infection with Trypanosoma cruzi.
Hoft DF; Lynch RG; Kirchhoff LV
J Immunol; 1993 Dec; 151(12):7038-47. PubMed ID: 8258708
[TBL] [Abstract][Full Text] [Related]
5. Isotype determination of anti-Trypanosoma cruzi antibody in murine Chagas' disease.
Rowland EC; Mikhail KS; McCormick TS
J Parasitol; 1992 Jun; 78(3):557-61. PubMed ID: 1375959
[TBL] [Abstract][Full Text] [Related]
6. Trypanosoma cruzi: immunity-induced in mice and rats by trypomastigote excretory-secretory antigens and identification of a peptide sequence containing a T cell epitope with protective activity.
Taibi A; Plumas-Marty B; Guevara-Espinoza A; Schöneck R; Pessoa H; Loyens M; Piras R; Aguirre T; Gras-Masse H; Bossus M
J Immunol; 1993 Sep; 151(5):2676-89. PubMed ID: 7689612
[TBL] [Abstract][Full Text] [Related]
7. Effect of the
Tasso LM; Bruballa AC; Garavaglia PA; Esteva MI; Albareda MC; García GA
Parasitology; 2020 Sep; 147(10):1114-1123. PubMed ID: 32466805
[TBL] [Abstract][Full Text] [Related]
8. Protection of mice against Trypanosoma cruzi by immunization with paraflagellar rod proteins requires T cell, but not B cell, function.
Miller MJ; Wrightsman RA; Stryker GA; Manning JE
J Immunol; 1997 Jun; 158(11):5330-7. PubMed ID: 9164953
[TBL] [Abstract][Full Text] [Related]
9. Trypanosoma cruzi: analysis of cellular and humoral response against a protective recombinant antigen during experimental Chagas' disease.
Taibi A; Espinoza AG; Ouaissi A
Immunol Lett; 1995 Dec; 48(3):193-200. PubMed ID: 8867851
[TBL] [Abstract][Full Text] [Related]
10. Efficient protective immunity against Trypanosoma cruzi infection after nasal vaccination with recombinant Sendai virus vector expressing amastigote surface protein-2.
Duan X; Yonemitsu Y; Chou B; Yoshida K; Tanaka S; Hasegawa M; Tetsutani K; Ishida H; Himeno K; Hisaeda H
Vaccine; 2009 Oct; 27(44):6154-9. PubMed ID: 19712768
[TBL] [Abstract][Full Text] [Related]
11. Acute Trypanosoma cruzi infection: IL-12, IL-18, TNF, sTNFR and NO in T. rangeli-vaccinated mice.
Basso B; Cervetta L; Moretti E; Carlier Y; Truyens C
Vaccine; 2004 May; 22(15-16):1868-72. PubMed ID: 15121297
[TBL] [Abstract][Full Text] [Related]
12. Trypanosoma cruzi: protective immunity in mice immunized with paraflagellar rod proteins is associated with a T-helper type 1 response.
Miller MJ; Wrightsman RA; Manning JE
Exp Parasitol; 1996 Nov; 84(2):156-67. PubMed ID: 8932765
[TBL] [Abstract][Full Text] [Related]
13. In vivo administration of recombinant IFN-gamma induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections.
Reed SG
J Immunol; 1988 Jun; 140(12):4342-7. PubMed ID: 3131431
[TBL] [Abstract][Full Text] [Related]
14. [Experimental Chagas' disease: I. Study of different immunization conditions in the infection course].
Introini MV; Basso B; Moretti E
Bol Chil Parasitol; 1998; 53(3-4):45-51. PubMed ID: 10413878
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease.
Bontempi IA; Vicco MH; Cabrera G; Villar SR; González FB; Roggero EA; Ameloot P; Callewaert N; Pérez AR; Marcipar IS
Vaccine; 2015 Mar; 33(10):1274-83. PubMed ID: 25625671
[TBL] [Abstract][Full Text] [Related]
16. Changes in isotype composition and antigen recognition of anti-Trypanosoma cruzi antibodies from acute to chronic Chagas disease.
Umezawa ES; Shikanai-Yasuda MA; Stolf AM
J Clin Lab Anal; 1996; 10(6):407-13. PubMed ID: 8951611
[TBL] [Abstract][Full Text] [Related]
17. Trypanosoma cruzi paraflagellar rod proteins 2 and 3 contain immunodominant CD8(+) T-cell epitopes that are recognized by cytotoxic T cells from Chagas disease patients.
Egui A; Thomas MC; Morell M; Marañón C; Carrilero B; Segovia M; Puerta CJ; Pinazo MJ; Rosas F; Gascón J; López MC
Mol Immunol; 2012 Oct; 52(3-4):289-98. PubMed ID: 22750229
[TBL] [Abstract][Full Text] [Related]
18. Recombinant SSP4 protein from Trypanosoma cruzi amastigotes regulates nitric oxide production by macrophages.
Ramos-Ligonio A; López-Monteon A; Talamás-Rohana P; Rosales-Encina JL
Parasite Immunol; 2004 Oct; 26(10):409-18. PubMed ID: 15752118
[TBL] [Abstract][Full Text] [Related]
19. Humoral and cellular immune responses in BALB/c and C57BL/6 mice immunized with cytoplasmic (CRA) and flagellar (FRA) recombinant repetitive antigens, in acute experimental Trypanosoma cruzi infection.
Pereira VR; Lorena VM; Nakazawa M; Luna CF; Silva ED; Ferreira AG; Krieger MA; Goldenberg S; Soares MB; Coutinho EM; Correa-Oliveira R; Gomes YM
Parasitol Res; 2005 Jun; 96(3):154-61. PubMed ID: 15856302
[TBL] [Abstract][Full Text] [Related]
20. Changes in humoral responses to Trypanosoma cruzi during the course of infection in mice held at elevated temperature.
Dimock KA; Davis CD; Kuhn RE
J Parasitol; 1992 Aug; 78(4):687-96. PubMed ID: 1635028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]